Supplementary Figure S2 from A Tumor-Naïve ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis from the GALAXY Study in CIRCULATE-Japan
Nakamura Y., Kaneva K., Lo C., Neems D., Freaney JE., Boulos H., Hyun SW., Islam F., Yamada-Hanff J., Driessen TM., Sonnenschein A., DeSantis DF., Kotani D., Watanabe J., Kotaka M., Mishima S., Bando H., Yamazaki K., Taniguchi H., Takemasa I., Kato T., Sangli C., Tell R., Blidner R., Yoshino T., Sasser K., Oki E., Nimeiri H.
<p>Figure S2. MRD status over time in non-recurrent study participants</p>

